The global peripheral vascular devices market is experiencing steady and sustained growth, driven by the rising prevalence of vascular diseases, an aging global population, and continuous advancements in minimally invasive medical technologies. In 2024, the market was valued at USD 11.21 billion and is projected to grow from USD 11.84 billion in 2025 to USD 18.32 billion by 2032, registering a compound annual growth rate (CAGR) of 6.43% during the forecast period.
Get Full Detailed PDF Report: https://www.kingsresearch.com/report/peripheral-vascular-devices-market-3018
Peripheral vascular devices are critical medical tools used in the diagnosis, treatment, and management of disorders affecting blood vessels outside the heart and brain. These devices play a vital role in improving patient outcomes by enabling less invasive procedures, reducing recovery times, and lowering the risk of complications associated with traditional surgical interventions.
Market Overview
Peripheral vascular diseases (PVDs) encompass a wide range of conditions that affect arteries and veins, particularly in the lower extremities, carotid arteries, and renal arteries. The increasing incidence of conditions such as peripheral artery disease (PAD), carotid artery disease, and renal artery disease has significantly increased the demand for advanced vascular intervention devices.
Peripheral vascular devices include angioplasty balloons, stents, catheters, atherectomy systems, and embolic protection devices, all of which are designed to restore blood flow, remove plaque, or prevent embolization during procedures. Technological innovation, combined with greater awareness among patients and healthcare providers, has positioned peripheral vascular devices as an essential component of modern cardiovascular care.
Key Market Drivers
Rising Prevalence of Peripheral Vascular Diseases
One of the primary drivers of the peripheral vascular devices market is the growing global burden of peripheral vascular diseases. Risk factors such as diabetes, hypertension, obesity, smoking, and sedentary lifestyles have contributed to an increase in vascular disorders, particularly among older populations. As life expectancy continues to rise, the demand for effective vascular treatments is expected to grow correspondingly.
Growing Adoption of Minimally Invasive Procedures
Minimally invasive endovascular procedures have become the preferred treatment option for many vascular conditions due to their reduced trauma, shorter hospital stays, and faster recovery times. Peripheral vascular devices enable physicians to perform complex interventions with greater precision and safety, accelerating their adoption across hospitals and specialty clinics.
Technological Advancements in Device Design
Continuous innovation in device materials, coatings, and designs has significantly improved the performance and safety of peripheral vascular devices. Drug-coated balloons, bioresorbable stents, and advanced embolic protection systems are enhancing procedural success rates and long-term patient outcomes, further driving market growth.
Expanding Healthcare Infrastructure
Improving healthcare infrastructure, particularly in emerging economies, is contributing to greater access to vascular diagnostic and treatment procedures. Increased healthcare spending and the expansion of specialized cardiovascular centers are supporting the widespread adoption of peripheral vascular devices.
Market Restraints
Despite positive growth trends, the market faces certain challenges. High device costs, limited reimbursement coverage in some regions, and the risk of procedural complications can restrict market expansion. Additionally, stringent regulatory requirements for medical device approvals may prolong product launch timelines, especially for new and innovative technologies.
Market Segmentation Analysis
By Product Type
Angioplasty Devices
Angioplasty devices account for a significant share of the peripheral vascular devices market. These devices are widely used to dilate narrowed or blocked blood vessels, restoring adequate blood flow. Balloon angioplasty systems, including drug-coated balloons, are increasingly preferred due to their effectiveness in reducing restenosis rates.
Stents
Stents are among the most commonly used peripheral vascular devices and are designed to provide structural support to blood vessels following angioplasty. The market includes bare-metal stents, drug-eluting stents, and bioresorbable stents. Continuous advancements in stent design have improved flexibility, durability, and long-term patency rates.
Atherectomy Devices
Atherectomy devices are used to remove atherosclerotic plaque from blood vessels, particularly in complex or heavily calcified lesions. These devices are gaining popularity due to their ability to improve vessel preparation and enhance the effectiveness of subsequent angioplasty or stent placement.
Embolic Protection Devices
Embolic protection devices play a critical role in preventing debris from traveling downstream during vascular interventions. These devices are especially important in carotid artery procedures, where embolization can lead to serious neurological complications.
Catheters
Catheters are essential tools in peripheral vascular interventions, used for diagnostic imaging, device delivery, and therapeutic procedures. The demand for advanced catheter systems with improved steerability and precision continues to grow.
Others
Other product types include guidewires, vascular closure devices, and imaging accessories, which support the overall procedural workflow and enhance treatment outcomes.
By Application
Peripheral Artery Disease
Peripheral artery disease represents the largest application segment in the peripheral vascular devices market. PAD primarily affects the lower extremities and is a major cause of morbidity worldwide. The increasing incidence of diabetes and smoking has significantly contributed to the growing demand for PAD-related interventions.
Carotid Artery Disease
Carotid artery disease is a major risk factor for stroke, driving the demand for carotid stents, embolic protection devices, and specialized catheters. Early diagnosis and preventive interventions are supporting growth in this segment.
Renal Artery Disease
Renal artery disease can lead to hypertension and kidney dysfunction if left untreated. The use of angioplasty and stenting procedures for renal artery interventions is increasing, contributing to market expansion.
Others
Other applications include venous diseases, dialysis access interventions, and treatment of trauma-related vascular injuries, further broadening the scope of peripheral vascular device usage.
By End User
Hospitals represent the largest end-user segment due to their advanced infrastructure, availability of skilled specialists, and ability to handle complex vascular procedures. Ambulatory surgical centers and specialty clinics are also witnessing increased adoption, driven by the growing preference for outpatient procedures and cost-effective care delivery models.
Regional Analysis
North America
North America dominates the global peripheral vascular devices market, supported by a high prevalence of vascular diseases, advanced healthcare infrastructure, and strong adoption of innovative medical technologies. The United States accounts for a major share of regional revenue due to favorable reimbursement policies and a well-established network of cardiovascular care centers.
Europe
Europe represents a significant market, driven by an aging population, increasing awareness of vascular health, and strong government support for advanced medical treatments. Countries such as Germany, the United Kingdom, and France are key contributors to regional growth.
Asia-Pacific
The Asia-Pacific region is expected to witness the fastest growth during the forecast period. Rising healthcare expenditure, improving diagnostic capabilities, and a growing patient population are driving demand for peripheral vascular devices in countries such as China, India, and Japan.
Latin America
Latin America is an emerging market for peripheral vascular devices, supported by improving healthcare infrastructure and increasing adoption of minimally invasive procedures. Brazil and Mexico are key markets within the region.
Middle East & Africa
The Middle East & Africa region is gradually expanding, driven by investments in healthcare modernization and rising awareness of cardiovascular diseases. While market penetration remains relatively lower, long-term growth potential remains strong.
Competitive Landscape
The peripheral vascular devices market is highly competitive, with key players focusing on product innovation, strategic collaborations, and geographic expansion. Companies are investing heavily in research and development to introduce next-generation devices that offer improved safety, durability, and clinical outcomes. Mergers, acquisitions, and partnerships are also shaping the competitive dynamics of the market.
Future Outlook
The future of the global peripheral vascular devices market is promising, supported by continued technological innovation, growing patient awareness, and the increasing adoption of minimally invasive vascular procedures. As healthcare systems worldwide prioritize early diagnosis and effective treatment of vascular diseases, the demand for advanced peripheral vascular devices is expected to rise steadily through 2032.
About Kings Research
Kings Research is a leading market research and consulting firm that provides comprehensive market intelligence and strategic insights to businesses across various industries.
